Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk In Communities study.

BackgroundSome obese adults are not afflicted by the metabolic abnormalities often associated with obesity (the 'metabolically healthy obese' (MHO)); however, they may be at increased risk of developing cardiometabolic abnormalities in the future. Little is known about the relative incidence of individual components of metabolic syndrome (MetSyn).MethodsWe used data from a multicenter, community-based cohort aged 45-64 years at recruitment (the Atherosclerosis Risk In Communities study) to examine the first appearance of any MetSyn component, excluding waist circumference. Body mass index (BMI, kg m-2) and cardiometabolic data were collected at four triennial visits. Our analysis included 3969 adults who were not underweight and free of the components of MetSyn at the initial visit. Participants were classified as metabolically healthy normal weight (MHNW), overweight (MHOW) and MHO at each visit. Adjusted hazard ratios (HR) and 95% confidence intervals were estimated with proportional hazards regression models.ResultsThe relative rate of developing each risk factor was higher among MHO than MHNW, with the strongest association noted for elevated fasting glucose (MHO vs MHNW, HR: 2.33 (1.77, 3.06)). MHO was also positively associated with elevated triglycerides (HR: 1.63 (1.27, 2.09)), low high-density lipoprotein-cholesterol (HR: 1.68 (1.32, 2.13)) and elevated blood pressure (HR: 1.54 (1.26, 1.88)). A similar, but less pronounced pattern was noted among the MHOW vs MHNW.ConclusionsWe conclude that even among apparently healthy individuals, obesity and overweight are related to more rapid development of at least one cardiometabolic risk factor, and that elevations in blood glucose develop most rapidly

IDENTIFICATION OF FLOOR AND VAULTING APTITUDE IN 8·14 YEAR OLD TALENT-SELECTED FEMALE GYMNASTS

Training programs can be designed and monitored to maximise high aptitude for floor and vault when the key attributes are identified, and then used to recognize apparatus ability in talent-selected gymnasts. The aim of this study was to identify the anthropometric and physical prerequisites for high difficulty floor tumbling and vaulting. Twenty female gymnasts performed handstand push-offs, single and multiple jumps on a portable Kistler force plate. The gymnasts were also examined when sprinting, vaulting, and performing broad jumps. Each gymnast's best vault, three best noor tumbling skills and their anthropometric characteristics were also recorded. High squat jump force and power, vault take-off velocity, and sprinting speed indicated vaulting talent. High vault running speed and reduced handstand push-off ground contact time indicated high floor ability

An algorithm for diagnosing IgE-mediated food allergy in study participants who do not undergo food challenge.

BACKGROUND: Food allergy diagnosis in clinical studies can be challenging. Oral food challenges (OFC) are time-consuming, carry some risk and may, therefore, not be acceptable to all study participants. OBJECTIVE: To design and evaluate an algorithm for detecting IgE-mediated food allergy in clinical study participants who do not undergo OFC. METHODS: An algorithm for trial participants in the Barrier Enhancement for Eczema Prevention (BEEP) study who were unwilling or unable to attend OFC was developed. BEEP is a pragmatic, multi-centre, randomized-controlled trial of daily emollient for the first year of life for primary prevention of eczema and food allergy in high-risk infants (ISRCTN21528841). We built on the European iFAAM consensus guidance to develop a novel food allergy diagnosis algorithm using available information on previous allergenic food ingestion, food reaction(s) and sensitization status. This was implemented by a panel of food allergy experts blind to treatment allocation and OFC outcome. We then evaluated the algorithm's performance in both BEEP and Enquiring About Tolerance (EAT) study participants who did undergo OFC. RESULTS: In 31/69 (45%) BEEP and 44/55 (80%) EAT study control group participants who had an OFC the panel felt confident enough to categorize children as "probable food allergy" or "probable no food allergy". Algorithm-derived panel decisions showed high sensitivity 94% (95%CI 68, 100) BEEP; 90% (95%CI 72, 97) EAT and moderate specificity 67% (95%CI 39, 87) BEEP; 67% (95%CI 39, 87) EAT. Sensitivity and specificity were similar when all BEEP and EAT participants with OFC outcome were included. CONCLUSION: We describe a new algorithm with high sensitivity for IgE-mediated food allergy in clinical study participants who do not undergo OFC. CLINICAL RELEVANCE: This may be a useful tool for excluding food allergy in future clinical studies where OFC is not conducted

NOVEL INSIGHTS ON LOWER LIMB MUSCULOSKELETAL HEALTH AND PERFORMANCE IN PRE-ADOLESCENT AND ADOLESCENT GYMNASTS

New analyses are presented from the data of Bradshaw and Le Rossignol (2004) to examine the relationship between musculoskeletal health, and physical and performance qualities, with measures of leg stiffness in a group of female gymnasts. A gymnasts leg stiffness can be assessed through continuous jump (straight & bent legged) series tests, as well as from rebound jumps. Although the observations are retrospective, the study revealed a potential safe zone for ankle extensor stiffness. The gymnast with low stiffness had previously suffered a landing ankle injury; whilst four gymnasts with high stiffness had histories of take-off ankle injuries. Aside from profiling physical performance qualities, biomechanical (kinetic) testing has the potential to also aid in the assessment and management of the athlete’s functional musculoskeletal health (rehabilitation, injury risk)

Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial.

BACKGROUND: Skin barrier dysfunction precedes eczema development. We tested whether daily use of emollient in the first year could prevent eczema in high-risk children. METHODS: We did a multicentre, pragmatic, parallel-group, randomised controlled trial in 12 hospitals and four primary care sites across the UK. Families were approached via antenatal or postnatal services for recruitment of term infants (at least 37 weeks' gestation) at high risk of developing eczema (ie, at least one first-degree relative with parent-reported eczema, allergic rhinitis, or asthma, diagnosed by a doctor). Term newborns with a family history of atopic disease were randomly assigned (1:1) to application of emollient daily (either Diprobase cream or DoubleBase gel) for the first year plus standard skin-care advice (emollient group) or standard skin-care advice only (control group). The randomisation schedule was created using computer-generated code (stratified by recruiting centre and number of first-degree relatives with atopic disease) and participants were assigned to groups using an internet-based randomisation system. The primary outcome was eczema at age 2 years (defined by UK working party criteria) with analysis as randomised regardless of adherence to allocation for participants with outcome data collected, and adjusting for stratification variables. This trial is registered with ISRCTN, ISRCTN21528841. Data collection for long-term follow-up is ongoing, but the trial is closed to recruitment. FINDINGS: 1394 newborns were randomly assigned to study groups between Nov 19, 2014, and Nov 18, 2016; 693 were assigned to the emollient group and 701 to the control group. Adherence in the emollient group was 88% (466 of 532) at 3 months, 82% (427 of 519) at 6 months, and 74% (375 of 506) at 12 months in those with complete questionnaire data. At age 2 years, eczema was present in 139 (23%) of 598 infants with outcome data collected in the emollient group and 150 (25%) of 612 infants in the control group (adjusted relative risk 0·95 [95% CI 0·78 to 1·16], p=0·61; adjusted risk difference -1·2% [-5·9 to 3·6]). Other eczema definitions supported the results of the primary analysis. Mean number of skin infections per child in year 1 was 0·23 (SD 0·68) in the emollient group versus 0·15 (0·46) in the control group; adjusted incidence rate ratio 1·55 (95% CI 1·15 to 2·09). INTERPRETATION: We found no evidence that daily emollient during the first year of life prevents eczema in high-risk children and some evidence to suggest an increased risk of skin infections. Our study shows that families with eczema, asthma, or allergic rhinitis should not use daily emollients to try and prevent eczema in their newborn. FUNDING: National Institute for Health Research Health Technology Assessment

Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial.

BACKGROUND: Skin barrier dysfunction precedes eczema development. We tested whether daily use of emollient in the first year could prevent eczema in high-risk children. METHODS: We did a multicentre, pragmatic, parallel-group, randomised controlled trial in 12 hospitals and four primary care sites across the UK. Families were approached via antenatal or postnatal services for recruitment of term infants (at least 37 weeks' gestation) at high risk of developing eczema (ie, at least one first-degree relative with parent-reported eczema, allergic rhinitis, or asthma, diagnosed by a doctor). Term newborns with a family history of atopic disease were randomly assigned (1:1) to application of emollient daily (either Diprobase cream or DoubleBase gel) for the first year plus standard skin-care advice (emollient group) or standard skin-care advice only (control group). The randomisation schedule was created using computer-generated code (stratified by recruiting centre and number of first-degree relatives with atopic disease) and participants were assigned to groups using an internet-based randomisation system. The primary outcome was eczema at age 2 years (defined by UK working party criteria) with analysis as randomised regardless of adherence to allocation for participants with outcome data collected, and adjusting for stratification variables. This trial is registered with ISRCTN, ISRCTN21528841. Data collection for long-term follow-up is ongoing, but the trial is closed to recruitment. FINDINGS: 1394 newborns were randomly assigned to study groups between Nov 19, 2014, and Nov 18, 2016; 693 were assigned to the emollient group and 701 to the control group. Adherence in the emollient group was 88% (466 of 532) at 3 months, 82% (427 of 519) at 6 months, and 74% (375 of 506) at 12 months in those with complete questionnaire data. At age 2 years, eczema was present in 139 (23%) of 598 infants with outcome data collected in the emollient group and 150 (25%) of 612 infants in the control group (adjusted relative risk 0·95 [95% CI 0·78 to 1·16], p=0·61; adjusted risk difference -1·2% [-5·9 to 3·6]). Other eczema definitions supported the results of the primary analysis. Mean number of skin infections per child in year 1 was 0·23 (SD 0·68) in the emollient group versus 0·15 (0·46) in the control group; adjusted incidence rate ratio 1·55 (95% CI 1·15 to 2·09). INTERPRETATION: We found no evidence that daily emollient during the first year of life prevents eczema in high-risk children and some evidence to suggest an increased risk of skin infections. Our study shows that families with eczema, asthma, or allergic rhinitis should not use daily emollients to try and prevent eczema in their newborn. FUNDING: National Institute for Health Research Health Technology Assessment

Mergers as triggers for nuclear activity : A near-IR study of the close environment of AGN in the VISTA-VIDEO survey

copyright 2014 The Authors; Published by Oxford University Press on behalf of the Royal Astronomical SocietyThere is an ongoing debate concerning the driver of nuclear activity in galaxies, with active galactic nuclei (AGN) either being triggered by major or minor galactic mergers or, alternatively, through secular processes like cold gas accretion and/or formation of bars. We investigate the close environment of active galaxies selected in the X-ray, the radio and the mid-IR. We utilize the first data release of the new near-IR VISTA Deep Extragalactic Observations (VIDEO) survey of the XMM-Large Scale Structure field. We use two measures of environment density, namely counts within a given aperture and a finite redshift slice (pseudo- 3D density) and closest neighbour density measures ∑2 and ∑5. We select both AGN and control samples, matching them in redshift and apparent Ks-band magnitude. We find that AGN are found in a range of environments, with a subset of the AGN samples residing in overdense environments. Seyfert-like X-ray AGN and flat-spectrum radio-AGN are found to inhabit significantly overdense environments compared to their control sample. The relation between overdensities and AGN luminosity does not however reveal any positive correlation. Given the absence of an environment density-AGN luminosity relation, we find no support for a scheme where high-luminosity AGN are preferentially triggered by mergers. On the contrary, we find that AGN likely trace over dense environments at high redshift due to the fact that they inhabit the most massive galaxies, rather than being an AGN.Peer reviewe

Lone mothers’ time allocations: Choices and satisfactions

This paper uses the 2006 Australian Time Use Survey to examine theallocation of time to personal care, employment-related activities, homeduties, leisure and child care of lone mothers, in comparison to the timeallocations of single women, women in childless couples and partneredmothers. Both primary and secondary time allocations are considered. Thesatisfactions that women report concerning their current time allocations arealso analysed. The time use and satisfaction data are described using bothtabulations and multiple regression methods. Lone mothers are shown tohave similar time allocations as the other types of households, even thoughthey have different financial and time resources. This raises the concernthat lone mothers’ desire or need to maintain such time allocations maylead to task overload. Consistent with this, lone mothers are found to beless satisfied with the way they allocate their time than single women andpartnered mothers. The tensions associated with time use among lonemothers discussed in the literature are real, and important

Dimethyl 2-[23-oxo-22,24-diphenyl-8,11,14-trioxa-25-aza­tetra­cyclo­[19.3.1.02,7.015,20]penta­cosa-2,4,6,15(20),16,18-hexaen-25-yl]but-2-enedioate

The title compound, C39H37NO8, is a product of the Michael addition of the cyclic secondary amine subunit of aza-14-crown-4 ether to dimethyl acetyl­enedicarboxyl­ate. The piperidinone ring exhibits a distorted chair conformation and the dimethyl acetyl­enedicarboxyl­ate fragment has a cis configuration with a dihedral angle of 56.61 (5)° between the two carboxyl­ate groups. The crystal packing is stabilized by the weak C—H⋯O hydrogen bonds

Sea surface temperature changes in the southern California borderlands during the last glacial-interglacial cycle

A variety of evidence suggests that average sea surface temperatures (SSTs) during the last glacial maximum in the California Borderlands region were significantly colder than during the Holocene. Planktonic foraminiferal δ18O evidence and average SST estimates derived by the modern analog technique indicate that temperatures were 6°-10°C cooler during the last glacial relative to the present. The glacial plankton assemblage is dominated by the planktonic foraminifer Neogloboquadrina pachyderma (sinistral coiling) and the coccolith Coccolithus pelagicus, both of which are currently restricted to subpolar regions of the North Pacific. The glacial-interglacial average SST change determined in this study is considerably larger than the 2°C change estimated by Climate: Long-Range Investigation, Mapping, and Prediction (CLIMAP) [1981]. We propose that a strengthened California Current flow was associated with the advance of subpolar surface waters into the Borderlands region during the last glacial